SciELO - Scientific Electronic Library Online

 
vol.45 número4Coenzyme Q10 and its effects in the treatment of neurodegenerative diseasesResponsible self-medication: review of the process of pharmaceutical attendance índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Brazilian Journal of Pharmaceutical Sciences

versão On-line ISSN 2175-9790

Resumo

SANTOS-OLIVEIRA, Ralph. Guidance for nuclear medicine staff on radiopharmaceuticals drug interaction. Braz. J. Pharm. Sci. [online]. 2009, vol.45, n.4, pp.619-624. ISSN 2175-9790.  http://dx.doi.org/10.1590/S1984-82502009000400003.

Numerous drug interactions related to radiopharmaceuticals take place every day in hospitals many of which are not reported or detected. Information concerning this kind of reaction is not abundant, and nuclear medicine staff are usually overwhelmed by this information. To better understand this type of reaction, and to help nuclear medicine staff deal with it, a review of the literature was conducted. The results show that almost all of radiopharmaceuticals marketed around the world present drug interactions with a large variety of compounds. This suggests that a logical framework to make decisions based on reviews incorporating adverse reactions must be created. The review also showed that researchers undertaking a review of literature, or even a systematic review that incorporates drug interactions, must understand the rationale for the suggested methods and be able to implement them in their review. Additionally, a global effort should be made to report as many cases of drug interaction with radiopharmaceuticals as possible. With this, a complete picture of drug interactions with radiopharmaceuticals can be drawn.

Palavras-chave : Nuclear medicine; Radiology; Radiopharmaceuticals [drug interaction]; Molecular imaging.

        · resumo em Português     · texto em Inglês     · Inglês ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons